Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Alkaline Ceramidase 1 prevents early hair loss in mice by keeping hair follicle stem cells balanced.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

JAK inhibitors offer new hope for treating severe alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Upadacitinib effectively treated severe hair loss in a child.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.